In our previous report, tumor samples from patients with lung adenocarcinoma showed MAFB expression in locations comparable to CD68- and CD204-positive TAMs and were abundant in severe stages of cancer [21]. This evidence concerns the gene MAFB and lung adenocarcinoma.